Krajska Nemocnice Liberec a.s.
About Krajska Nemocnice Liberec a.s.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bayer
5
Janssen Research & Development, LLC
4
Boehringer Ingelheim
3
Henogen
3
AO Clinical Investigation and Publishing Documentation
1
AZTherapies, Inc.
1
Achieve Life Sciences
1
Aesculap AG
1
Alizyme
1
Baxter Healthcare Corporation
1
Biocad
1
Clinical Trials at Krajska Nemocnice Liberec a.s.
During the past decade, Krajska Nemocnice Liberec a.s. conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 10 clinical trials were completed, i.e. on
average, 43.5% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 6 clinical trials were completed. i.e. 54.5%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to GSK Biologicals Adjuvanted Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Have Not Been Exposed to Hepatitis B.
2006-02-01
2007-03-01
Completed
300
A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Responded to Previous Hepatitis B Vaccination But Lost Antibody.
2006-03-01
2007-10-01
Completed
185
Study of COLAL-PRED® in the Treatment of Moderate Acute Ulcerative Colitis
2006-03-01
2008-04-01
Completed
796
Study Evaluating Persistence of Anti-HBs Antibodies in Uraemic Patients Receiving Henogen's HBV Vaccine, or Fendrix™
2007-03-01
2009-11-01
Completed
102
Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)
2007-12-01
2009-11-01
Terminated
5,000
2-arm Trial of Paclitaxel Plus Bevacizumab vs. Capecitabine Plus Bevacizumab
2008-04-01
2014-12-01
Completed
564
Phase III Study to Investigate the Safety and Efficacy of Fermagate and Sevelamer Hydrochloride
2009-07-01
2011-10-01
Terminated
1,000
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Krajska Nemocnice Liberec a.s." #1 sponsor was "Bayer" with 5 trials, followed by "Janssen Research & Development, LLC" with 4 trials
sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "Henogen" with 3 trials sponsored and "AO Clinical Investigation and Publishing Documentation"
with 3 trials sponsored. Other sponsors include 28 different institutions and
companies that sponsored additional 38 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Krajska Nemocnice Liberec a.s."
#1 collaborator was "Charles University, Czech Republic" with 2 trials as a collaborator, "GlaxoSmithKline" with 2 trials as a collaborator, "University Hospital Pilsen" with 2 trials as a collaborator, "ABX CRO" with 1 trials as a collaborator and "AG Mednet Inc." with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were
collaborators in the rest 25 trials.
Clinical Trials Conditions at Krajska Nemocnice Liberec a.s.
According to Clinical.Site data, the most researched conditions in "Krajska Nemocnice Liberec a.s." are
"Hepatitis B" (3 trials), "Atrial Fibrillation" (2 trials), "Cardiogenic Shock" (2 trials), "Heart Failure" (2 trials) and "Myocardial Infarction" (2 trials). Many other conditions were trialed in "Krajska Nemocnice Liberec a.s." in a lesser frequency.
Clinical Trials Intervention Types at Krajska Nemocnice Liberec a.s.
Most popular intervention types in "Krajska Nemocnice Liberec a.s." are "Drug" (32 trials), "Other" (8 trials), "Biological" (7 trials), "Device" (5 trials) and "Procedure" (5 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (13 trials), "Gemcitabine" (2 trials), "Niraparib" (2 trials), "Paclitaxel" (2 trials) and "Pemetrexed" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Krajska Nemocnice Liberec a.s.
The vast majority of trials in "Krajska Nemocnice Liberec a.s." are
43 trials for "All" genders, 5 trials for "Male" genders and 1 trials for "Female" genders.
Clinical Trials Status at Krajska Nemocnice Liberec a.s.
Currently, there are NaN active trials in "Krajska Nemocnice Liberec a.s.".
undefined are not yet recruiting,
9 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 27 completed trials in Krajska Nemocnice Liberec a.s.,
undefined suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Krajska Nemocnice Liberec a.s., 1 "Phase 1"
clinical trials were conducted, 8 "Phase 2" clinical
trials and 26 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 4 trials, and there were
also 7 trials that are defined as “Not Applicable".